Unichem Pharmaceuticals USA Inc. recalls Doxazosin Tablets
- Recalling company
- Unichem Pharmaceuticals USA Inc.
- Product
- Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
- Reason
- Tablets/Capsules Imprinted with Wrong ID
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Jan 21, 2026
- Reported
- Feb 18, 2026
- Distribution
- Nationwide
- Status
- Ongoing
- Quantity
- 60,000 tablets
- Lot / codes
- Lot # GDSH25006, Exp Date: 08/2027
- Company location
- East Brunswick, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0306-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0306-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.